LifeArc joins £20m international project to develop novel cancer treatment for children

LifeArc is investing up to £4.9 million to bolster a joint international project to create new cancer…

LifeArc’s Edinburgh labs featured in STV segment about innovations for people living with bronchiectasis

Recently, our team had the pleasure of hosting STV for an exciting feature at the BioQuarter campus…

LifeArc welcomes Labour Life Sciences sector plan

Ahead of an upcoming general election, it is important that all political parties consider how they would…

LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa

LifeArc and the Bill & Melinda Gates Foundation are jointly investing £6 million ($7.2m) in the Grand…

Two influential life science leaders join LifeArc science team

This quarter, we look forward to welcoming 2 new colleagues – Heather McKinnon and Giovanna Lalli –…

NHS trial uses artificial intelligence to predict severe infections and transform lives of people living with chronic lung conditions

A new NHS trial is using a home monitoring app combined with artificial intelligence (AI) to predict…

2023 wrapped: Our highlights from a successful year

As 2023 comes to a close, we reflect on another great year at LifeArc filled with, exciting…

LifeArc contributes to revitalisation of groundbreaking science education centre for children and young people

Centre of the Cell is the first informal science education centre in the world to be located…

LifeArc announces £5 million drug repurposing programme for motor neuron disease

LifeArc is launching new £5m programme to help find new treatments for motor neuron disease (MND). The…